ESMO Congress 2019: What to Expect
Preview key science that will be presented during the European Society of Medical Oncology’s 2019 Congress.
All articles by Cancer Therapy Advisor Staff
Phase 3 Trial Compares Standard-Dose Versus High-Dose Combination Chemo With Stem Cell Transplant for Germ Cell Tumors
Giving chemotherapy before a stem cell transplant stops the growth of cancer cells by stopping them from dividing or killing them.
LIBRETTO-121: A Phase 1/2 Trial Investigating LOXO-292 in Pediatric Patients With Advanced Solid or Primary CNS Tumors
A primary outcome measure for phase 1 of the trial is determining the safety of oral LOXO-292.
Phase 1/2 Study of Durvalumab and Tremelimumab in Pediatric Cancer
After phase 1, the study will expand in a second phase to test the efficacy of these drugs at the determine dosage.
Clinical Trial Assesses Combination Chemotherapy With or Without Temsirolimus for Intermediate-Risk Rhabdomyosarcoma
Combination chemotherapy and temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Trial to Assess Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine in Pediatric Patients With Hodgkin Lymphoma
The purpose of this study is to assess the safety, tolerability, and antitumor activity, as well as recommended dose of brentuximab vedotin in combination with a multiagent chemotherapy regimen.
SGO Annual Meeting on Women’s Cancer: What to Expect
Preview key themes and trends that will be presented during the Society of Gynecologic Oncology (SGO)’s 50th Annual Meeting on Women’s Cancer.
Pilot Study Seeks to Assess Physical Activity Program in Patients With Gastrointestinal Cancer
Researchers are seeking to assess a physical activity program program in patients with gastrointestinal cancer.
Early Phase 1 Trial Investigating Postoperative Treatment Selection After Preoperative Chemotherapy for Gastric Cancers
Researchers are seeking to determine the feasibility of receiving either postoperative chemoradiation or chemotherapy, based on nodal status at surgery.
Phase 1, 2 Trials to Assess Imaging System for Gastrointestinal Cancer Detection
Researchers are seeking to assess the initial safety and efficacy of LUM015 imaging of colorectal, pancreatic, and esophageal cancers using the LUM 2.6 imaging device.
Next post in Gastrointestinal Cancers
